News

Drs. Anthony Fauci, Lee Hood Talk COVID-19, Vaccines, Future of Research, More

ISB’s Dr. Lee Hood presented the PMWC Luminary Award to Dr. Anthony Fauci on Monday, and the two renowned scientists engaged in an interesting hour-long conversation. 

The Luminary Award was presented on behalf of Precision Medicine World Conference on the first day of PMWC COVID, a three-day virtual event. The award recognizes contributions of prominent figures who have accelerated personal medicine to the clinic.

Hood spoke with Fauci, director of the National Institute of Allergy and Infectious Disease, about a number of topics, including the importance of basic research, the extraordinary speed of COVID research, the efficacy of mRNA vaccines on COVID-19 and the technology’s promise for creating effective vaccines for other diseases (including some cancers), lessons learned from the COVID-19 pandemic, and more. 

“We should have a vaccine, as well as universally applicable antivirals, that we could use for the next outbreak,” Fauci said. “I would be really disappointed if when this is over we don’t put together a commission and codify what we need to do as opposed to saying ‘well, we got through that, now let’s worry about the next problem’.”

You can watch the conversation here or by playing the video above.

Recent Articles

  • A New Approach to Alzheimer’s Disease

    The impact of Alzheimer’s Disease is staggering – 6 million Americans diagnosed, a financial toll of $600 billion annually, and no effective drug treatments. ISB Co-founder Dr. Lee Hood said the traditional approach isn’t working, and we need to think about it in brand new ways.

  • David Sinclair On Why We Age — And Why We Don’t Have To

    Dr. David Sinclair, a Harvard Medical School professor and New York Times bestselling author, was the guest of honor for the ISB-Town Hall Science Series on Thursday. He joined genomics pioneer and ISB Co-founder Dr. Lee Hood for a conversation that covered the very latest in aging research.

  • NYT Illustration

    ISB Research on the Aging Microbiome Featured in The New York Times

    ISB’s research into the aging microbiome was featured in a story published by Anahad O’Connor for The New York Times titled “A Changing Gut Microbiome May Predict How Well You Age.” The research featured was published in Nature Metabolism by Drs. Tomasz Wilmanksi, Noa Rappaport, Sean Gibbons and Nathan Price.